Health · 23 views
FDA panel considers a first-of-its-kind flu vaccine using mRNA technology
Moderna seeks FDA approval of its new shot, mFlusvia, as option for 50 and older US health advisers are debating a new kind of flu vaccine on Thursday, the first made with the same mRNA technology that was key to ending the Covid-19 pand…
Summary
Moderna seeks FDA approval of its new shot, mFlusvia, as option for 50 and older US health advisers are debating a new kind of flu vaccine on Thursday, the first made with the same mRNA technology that was key to ending the Covid-19 pandemic.
AI summaries can be wrong sometimes—always verify important details using the source article.
How AI & Automation are usedMore from Health
Continue reading recent Health coverage
- Australian pollen season may be arriving early in eastern statesContinue reading
- An administrative gap delays access to new pancreatic cancer treatmentContinue reading
- The key to successful treatment of primary aldosteronism: Get it earlyContinue reading
- Children with cancer are being saved, but are we breaking them in the process?Continue reading
Support HappeningNow
Independent AI-powered news analysis is reader-supported. Your contribution helps cover infrastructure, summaries, and continued platform development.
Support HappeningNow